XML 31 R17.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-based Compensation
3 Months Ended
Mar. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-based Compensation

9. Stock-based Compensation

During the three months ended March 31, 2021, the Company recognized the following stock-based compensation expense (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2021

 

 

2020

 

Research and development

 

$

12,845

 

 

$

7,362

 

General and administrative

 

 

9,247

 

 

 

6,789

 

Total

 

$

22,092

 

 

$

14,151

 

 

 

Stock option activity

The following table summarizes stock option activity for the three months ended March 31, 2021:

 

 

 

Shares

 

 

Weighted-

average

exercise price

per share

 

Outstanding at December 31, 2020

 

 

8,101,980

 

 

$

42.44

 

Granted

 

 

882,558

 

 

 

139.05

 

Exercised

 

 

(342,471

)

 

 

33.12

 

Cancelled or forfeited

 

 

(69,404

)

 

 

43.31

 

Outstanding at March 31, 2021

 

 

8,572,663

 

 

$

52.76

 

Exercisable at March 31, 2021

 

 

3,962,897

 

 

$

31.48

 

Vested and expected to vest at March 31, 2021

 

 

8,572,663

 

 

$

52.76

 

 

 

As of March 31, 2021, total unrecognized compensation expense related to stock options was $191.3 million, which the Company expects to recognize over a remaining weighted-average period of 3.1 years.

 

Restricted stock activity

The following table summarizes restricted stock activity for the three months ended March 31, 2021:

 

 

 

Restricted

Stock

 

 

Weighted-

Average

Grant Date

Fair Value

 

Unvested balance as of December 31, 2020

 

 

894,092

 

 

$

70.55

 

Granted

 

 

278,645

 

 

 

136.16

 

Vested

 

 

(109,355

)

 

 

40.64

 

Cancelled or forfeited

 

 

(11,003

)

 

 

57.94

 

Unvested balance as of March 31, 2021

 

 

1,052,379

 

 

$

91.16

 

 

As of March 31, 2021, total unrecognized compensation expense related to unvested restricted common shares was $76.5 million, which the Company expects to recognize over a remaining weighted-average vesting period of 2.8 years.